We’re excited to share a recent interview with Zalán Péterfi, Co-Founder and Chairman of the Board of Novamigra, featured in Világgazdaság!
In this conversation, we discuss our journey in developing an innovative Hungarian migraine treatment, the challenges of pharmaceutical R&D, and how we are positioning ourselves for global impact.
From groundbreaking research to regulatory pathways, we are committed to bringing effective and accessible solutions to migraine patients worldwide. This interview sheds light on our strategy, scientific breakthroughs, and the future of migraine therapy.
Read the full article (in Hungarian) by clicking on the link below.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
